1326: Phase II Trial of Gemcitabine, Paclitaxel, and Cisplatin in Advanced Transitional Cell Carcinoma

Cell Carcinoma ◽

Phase Ii ◽

Phase Ii Trial ◽

Phase II trial of cisplatin (C), fixed-dose rate gemcitabine (G) and gefitinib for advanced transitional cell carcinoma (TCC) of the urothelial tract: Preliminary results of CALGB 90102

10.1200/jco.2004.22.14_suppl.4540 ◽

2004 ◽

Vol 22 (14_suppl) ◽

pp. 4540-4540 ◽

Author(s):

G. Philips ◽

S. Halabi ◽

B. Sanford ◽

D. Bajorin ◽

E. Small

Keyword(s):

Cell Carcinoma ◽

Dose Rate ◽

Phase Ii ◽

Phase Ii Trial ◽

Transitional Cell ◽

Fixed Dose ◽

Preliminary Results ◽

Fixed Dose Rate

Weekly paclitaxel (P) plus carboplatin (C) as salvage therapy in metastatic transitional cell carcinoma (TCC) of the urothelium previously treated with MVAC: Phase II trial

10.1200/jco.2005.23.16_suppl.4719 ◽

2005 ◽

Vol 23 (16_suppl) ◽

pp. 4719-4719

Author(s):

T. Kouno ◽

M. Ando ◽

K. Yonemori ◽

K. Matsumoto ◽

C. Shimizu ◽

...

Keyword(s):

Cell Carcinoma ◽

Phase Ii ◽

Salvage Therapy ◽

Phase Ii Trial ◽

Transitional Cell ◽

Weekly Paclitaxel ◽

Previously Treated

A single arm, multicenter, phase II trial of everolimus as monotherapy in the palliative treatment of patients with locally advanced or metastatic transitional cell carcinoma after failure of platinum-based chemotherapy.

10.1200/jco.2010.28.15_suppl.e15087 ◽

2010 ◽

Vol 28 (15_suppl) ◽

pp. e15087-e15087 ◽

Author(s):

E. Seront ◽

S. Rottey ◽

B. Sautois ◽

L. A. D'Hondt ◽

J. R. Canon ◽

...

Keyword(s):

Cell Carcinoma ◽

Phase Ii ◽

Palliative Treatment ◽

Phase Ii Trial ◽

Locally Advanced ◽

Transitional Cell ◽

Multicenter Phase ◽

Platinum Based Chemotherapy

Phase II Trial With Cisplatin, Doxorubicin, and Cyclophosphamide (CAP) in the Treatment of Urothelial Transitional Cell Carcinoma

The Journal of Urology ◽

10.1016/s0022-5347(17)52702-0 ◽

1983 ◽

Vol 129 (6) ◽

pp. 1285-1285

Author(s):

M. Campbell ◽

L.H. Baker ◽

M. Opipari ◽

M. Al-Sarraf

Keyword(s):

Cell Carcinoma ◽

Phase Ii ◽

Phase Ii Trial ◽

Neo-adjuvant treatment of infiltrating transitional-cell carcinoma of the bladder with paclitaxel and cisplatin: A phase II trial

International Journal of Urology ◽

10.1046/j.1442-2042.2002.00443.x ◽

2002 ◽

Vol 9 (3) ◽

pp. 162-166 ◽

Author(s):

ALEJANDRO SOUSA-ESCANDÓN ◽

SERGIO VAZQUEZ ◽

GUILLERMO QUINTERO-ALDANA ◽

JOSE A PICALLO ◽

JAVIER NEIRA ◽

...

Keyword(s):

Cell Carcinoma ◽

Phase Ii ◽

Adjuvant Treatment ◽

Phase Ii Trial ◽

Transitional Cell ◽

Carcinoma Of The Bladder

A phase II trial of gemcitabine and carboplatin (GC) in patients with transitional cell carcinoma of the urinary tract (TCC)

10.1200/jco.2004.22.14_suppl.4590 ◽

2004 ◽

Vol 22 (14_suppl) ◽

pp. 4590-4590 ◽

Author(s):

J. Olivares ◽

W. Hyman ◽

N. Senzer

Keyword(s):

Urinary Tract ◽

Cell Carcinoma ◽

Phase Ii ◽

Phase Ii Trial ◽

Phase II trial of cisplatin (C), fixed-dose rate gemcitabine (G) and gefitinib for advanced transitional cell carcinoma (TCC) of the urothelial tract: Preliminary results of CALGB 90102

10.1200/jco.2004.22.90140.4540 ◽

2004 ◽

Vol 22 (14_suppl) ◽

pp. 4540-4540 ◽

Cited By ~ 2

Author(s):

G. Philips ◽

S. Halabi ◽

B. Sanford ◽

D. Bajorin ◽

E. Small

Keyword(s):

Cell Carcinoma ◽

Dose Rate ◽

Phase Ii ◽

Phase Ii Trial ◽

Transitional Cell ◽

Fixed Dose ◽

Preliminary Results ◽

Fixed Dose Rate

Phase II trial of gemcitabine, paclitaxel, and cisplatin in advanced transitional cell carcinoma

10.1200/jco.2004.22.90140.4610 ◽

2004 ◽

Vol 22 (14_suppl) ◽

pp. 4610-4610

Author(s):

P. E. Clark ◽

D. Stindt ◽

M. C. Hall ◽

M. Harmon ◽

J. F. Lovato ◽

...

Keyword(s):

Cell Carcinoma ◽

Phase Ii ◽

Phase Ii Trial ◽

A phase II trial of gemcitabine and carboplatin (GC) in patients with transitional cell carcinoma of the urinary tract (TCC)

10.1200/jco.2004.22.90140.4590 ◽

2004 ◽

Vol 22 (14_suppl) ◽

pp. 4590-4590

Author(s):

J. Olivares ◽

W. Hyman ◽

N. Senzer

Keyword(s):

Urinary Tract ◽

Cell Carcinoma ◽

Phase Ii ◽

Phase Ii Trial ◽

JEVTCC: Phase II trial of cabazitaxel (Cbz) in patients (pt) with advanced or metastatic transitional-cell carcinoma (mTCC), who progressed before 12 months after cisplatin-based chemotherapy—A Spanish Oncologic Genitourinary Group (SOGUG) study.

10.1200/jco.2015.33.15_suppl.4525 ◽

2015 ◽

Vol 33 (15_suppl) ◽

pp. 4525-4525 ◽

Cited By ~ 1

Author(s):

Jose Angel Arranz Arija ◽

Xavier Garcia del Muro ◽

Begoña Perez-Valderrama ◽

Sergio Vazquez-Estevez ◽

Nuria Sala ◽

...

Keyword(s):

Cell Carcinoma ◽

Phase Ii ◽

Phase Ii Trial ◽